1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Pontine Glioma Global Clinical Trials Review, H1, 2014

Pontine Glioma Global Clinical Trials Review, H1, 2014

  • March 2014
  • -
  • Global Data
  • -
  • 95 pages

Pontine Glioma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Pontine Glioma Global Clinical Trials Review, H1, 2014" provides data on the Pontine Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pontine Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pontine Glioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Pontine Glioma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Pontine Glioma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Pontine Glioma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Pontine Glioma 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Pontine Glioma Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Oncoscience AG 26
Clinical Trial Overview of Oncoscience AG 26
Gilead Sciences, Inc. 27
Clinical Trial Overview of Gilead Sciences, Inc. 27
Clinical Trial Overview of Top Institutes / Government 28
National Cancer Institute 28
Clinical Trial Overview of National Cancer Institute 28
Children's Oncology Group 29
Clinical Trial Overview of Children's Oncology Group 29
Children's Cancer and Leukaemia Group 30
Clinical Trial Overview of Children's Cancer and Leukaemia Group 30
Cancer Research UK 31
Clinical Trial Overview of Cancer Research UK 31
The University of Texas M. D. Anderson Cancer Center 32
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 32
Sidney Kimmel Comprehensive Cancer Center 33
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 33
Weill Cornell Medical College 34
Clinical Trial Overview of Weill Cornell Medical College 34
Hadassah Medical Organization 35
Clinical Trial Overview of Hadassah Medical Organization 35
Five Key Clinical Profiles 36
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 95

List of Tables
Pontine Glioma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Pontine Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Pontine Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Pontine Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Pontine Glioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Pontine Glioma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Pontine Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Pontine Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Pontine Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Pontine Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Pontine Glioma Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Pontine Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Pontine Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Pontine Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Pontine Glioma Therapeutics, Global, Suspended Clinical Trials, 2014* 20
Pontine Glioma Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Pontine Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Pontine Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Pontine Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Pontine Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Pontine Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncoscience AG, 2014* 26
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 27
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 28
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 29
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Cancer and Leukaemia Group, 2014* 30
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2014* 31
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 32
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014* 33
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2014* 34
Pontine Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 35

List of Figures
Pontine Glioma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Pontine Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Pontine Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Pontine Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Pontine Glioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Pontine Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Pontine Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Pontine Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Pontine Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Pontine Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Pontine Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Pontine Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Pontine Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Pontine Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Pontine Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Pontine Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Pontine Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 93

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Epiomic Epidemiology Series: Cervical Cancer Forecast in 22 Major Markets 2016 - 2026

Epiomic Epidemiology Series: Cervical Cancer Forecast in 22 Major Markets 2016 - 2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cervical Cancer in 22 Major Markets Cervical cancer (ICD-10 code C53, cervix uteri) is a type of cancer that occurs in the cells of ...

Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025

  • $ 4995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.